Kiona Foundation Inc. · 501(c)(3) Public Charity

Novel botanical drug discovery, anchored in pharmacognosy.

In honor of those we have lost. In service of those still here.

We advance rigorous, IRB-registered research into the endocannabinoid system, pursued through the FDA Botanical Drug Development pathway, in search of less toxic, more effective options for patients where conventional therapy has been inadequate.

Kiona Foundation childhood cancer awareness graphic: One step at a time, you'll get there. Stomp Out Cancer.
2003Founded
501(c)(3)Public charity since 2004
IRBRegistered research study
11International ecosystem nodes
Kiona Foundation billboard campaign: text KIONAFOUNDATION to 53-555

Who We Are

A public charity built on research, sovereignty, and honor.

Kiona Foundation Inc. is a 501(c)(3) public charity advancing novel botanical drug discovery, anchored in pharmacognosy, the study of medicines derived from natural sources. We pursue the FDA Botanical Drug Development pathway in search of less toxic, more effective options for patients where conventional therapy has been inadequate.

Research

Evidence before claims

IRB-registered clinical research under OHRP Federal-Wide Assurance FWA00034558, including the active KF-ECS-2025 endocannabinoid system study.

Sovereignty

Land and self-determination

Regenerative agriculture and Indigenous land partnerships across Wayne County, New York and eleven international ecosystem nodes.

Honor

For the children, for the families

Founded in 2003 in honor of Kiona Tejan Jenkins. We carry the work forward for the children, and for the families still walking the road.

Our Science

From plant knowledge to a defensible drug development pathway.

Our framing is deliberate and sequential. Each stage disciplines the next, so that traditional botanical knowledge is carried forward as rigorous, regulatable science rather than unsupported claim.

Pharmacognosy

The scientific study of medicines derived from natural sources, our foundation and first discipline.

Botanical Drug Discovery

Identifying and characterizing plant-derived candidates with genuine therapeutic potential.

FDA Botanical Pathway

Advancing candidates through the FDA Botanical Drug Development pathway, the regulatory standard for botanicals.

IRB-Registered Research

Human-subjects research under federal assurance, studying endocannabinoid system modulation.

The Equity Case

Directing the science toward health, agricultural, and Indigenous equity outcomes.

Active Research

KF-ECS-2025

Our active, IRB-approved study examines endocannabinoid system deficiency across general, clinical, and medically authorized adult and pediatric populations. It is conducted under federal human-subjects protections and led by an independent research team.

EIN20-0977421
OHRP AssuranceFWA00034558
IORG RegistrationIORG0012116
StudyKF-ECS-2025

Study Title

Endocannabinoid System Deficiency: A Comprehensive Study of General, Clinical, and Medically Authorized Adult and Pediatric Populations.

Approved September 2024. Informed consent offered in English, Spanish, and Haitian Creole, so that participation is not gated by language.

Research Leadership

LJ

Dr. Lakisha Jenkins-Samuels, Ph.D., RH (AHG)

Founder & President · Principal Investigator

Traditional Naturopath and Clinical Herbalist with more than two decades in botanical medicine, systems-based health, and health equity.

LinkedIn →
DV

Dr. Denise C. Vidot, Ph.D.

Co-Principal Investigator

Tenured Associate Professor, University of Miami Miller School of Medicine. Founding Director, Global Cannabis & Psychedelics Research Collaboratory.

LinkedIn →
MH

Dr. Maurice D. Hinson, MD

Co-Investigator

Founding Director, MediRootz Medical Group, Queens, New York.

LinkedIn →
IRB

Institutional Oversight

Independent IRB

Human-subjects protections are overseen by an independent Institutional Review Board under the Foundation's federal-wide assurance, safeguarding participant welfare and research integrity.

Initiatives

Where the research meets the ground.

Our programs translate the science into land, policy, and community, from a research campus in New York to international policy advocacy.

Macedon, New York

Home for Hope Project

A unified research, cultivation, processing, and clinical campus in Wayne County, developed with state and federal partners across two tracks: industrial hemp and medical Cannabis research. A Finger Lakes restoration story rooted in Erie Canal agricultural heritage.

International Policy

Liberia 2030: From Soil to Sovereignty

Formal policy advocacy providing the scientific, clinical, and regulatory foundation for sovereign botanical development, submitted to national leadership in 2026 as part of a broader international research network.

Community Campaign

Coins for Carly

A community campaign in loving memory of Carlene Omega Janae Samuels, known as Carly, supporting families facing pediatric illness where conventional care falls short. Follow the campaign at @coinsforcarly.

The Gift of Life

Fund the research that others will not.

Independent research needs independent support. Your gift funds IRB-registered study, community programs, and the equity work at the center of our mission.

Give to the Kiona Foundation

Donations are securely processed through Givebutter, our verified giving platform. One-time and recurring gifts support our research and programs directly.

Donate on Givebutter

Kiona Foundation Inc. is a 501(c)(3) public charity, EIN 20-0977421. Contributions are tax-deductible to the extent allowed by law.

  • Give by mailChecks payable to Kiona Foundation Inc.
    1159 2nd Ave #111, New York, NY 10065
  • Recurring giftsSet up monthly support through Givebutter to sustain the research year-round.
  • Partner with usFunders, academic collaborators, and institutional partners: contact us at contact@kionafoundation.org.
  • Follow the work@kionafoundation across social platforms.